Cabbacis

Cabbacis (OTCQB: CABI) is pioneering tobacco harm-reduction with iBlend™—low-nicotine tobacco & hemp cigarettes for the 1B smokers globally.

[Cabbacis @cabbacis]

Cigarette use among U.S. adults has now fallen below 11% — a historic low as consumers rapidly migrate toward lower-risk alternatives. The tobacco landscape is being redrawn in real time.

https://t.co/8labWNWQQl

#HarmReduction #Tobacco #SmokeFree #SmallCap $CABI

[Cabbacis @cabbacis]

Cabbacis CEO Joseph Pandolfino joined @KarenJagoda and the Empowered Patient Podcast to discuss iBlend — low-nicotine tobacco + hemp cigarettes that cut nicotine ~95% to help smokers.

Listen now: https://t.co/4D7NRfh53M

$CABI #HarmReduction

[Cabbacis @cabbacis]

In 40 U.S. states, smokers can be charged up to 50% more for health insurance premiums under the ACA. The financial case for switching has never been clearer. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/AWxVgXEUQM

[Cabbacis @cabbacis]

A smoker costs employers nearly $6,000 more per year than a non-smoker. Demand for alternatives has never been more urgent. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/80UfEJbNBI

#HarmReduction #Tobacco $CABI

[Cabbacis @cabbacis]

418 U.S. jurisdictions now restrict flavored tobacco sales. The regulatory walls around conventional tobacco keep closing in. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.
https://t.co/gr5lPsnzpH

#HarmReduction #Tobacco

[Cabbacis @cabbacis]

Cabbacis to Participate in Noble Capital Markets' Emerging Growth Equity Conference on June 3-4, 2026.

Click here for details: https://t.co/NYXoAKMHaN

#NobleConference $CABI

[Cabbacis @cabbacis]

Philip Morris generated $17B from smoke-free products in 2025 — even the world's largest tobacco company is betting on harm reduction. $CABI supports lower-nicotine, hemp-enhanced products developed for adult use.

Article: https://t.co/mIy1EcenuF

#HarmReduction #Tobacco

[Cabbacis @cabbacis]

Cabbacis to Participate in the Sidoti Micro-Cap Conference on May 20-21, 2026.

Click here for details: https://t.co/59W9qsyKRK

#Sidoti #Conference $CABI

[Cabbacis @cabbacis]

Tobacco alternatives are reshaping retail, nicotine alternatives now hold nearly 8% of total nicotine volume in c-stores & growing, as traditional cigarettes lose shelf share. The retail landscape is turning.

https://t.co/qLsdAYCR1y

#HarmReduction #Tobacco $CABI

[Cabbacis @cabbacis]

35% of Gen Z say smoking was part of their teen experience, demand for cleaner alternatives is surging fast. Cabbacis supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

Article: https://t.co/4jhIDRJVtU

#HarmReduction $CABI

[Cabbacis @cabbacis]

Cabbacis Reports Full Year 2025 Financial Results and Provides Corporate Update.

Click here for details: https://t.co/zoH4Jrqlwi

$CABI

[Cabbacis @cabbacis]

The natural herbal cigarettes market is projected to nearly double — from $1.5B to $2.8B by 2033 at a 7.5% CAGR — as consumers shift toward plant-based, tobacco-free alternatives.

Article: https://t.co/gAWSB33DCT #HarmReduction

#HerbalCigarettes #Wellness #SmallCap $CABI

[Cabbacis @cabbacis]

The WHO's 2025 Global Tobacco Report: 155 countries have now adopted tobacco control measures — global policy is pushing hard toward lower-nicotine, reduced-risk products.

https://t.co/YMfPrXNuyW

#HarmReduction #GlobalHealth #Tobacco #SmallCap $CABI

[Cabbacis @cabbacis]

A landmark NEJM clinical trial found reduced-nicotine cigarettes cut dependence, lowered toxicant exposure & increased quit attempts without compensatory smoking. Science is validating the harm-reduction model.

https://t.co/Q0aA0N4WQT

#HarmReduction #Tobacco #SmallCap $CABI

[Cabbacis @cabbacis]

The hemp herbal cigarette market is growing at 11.6% CAGR — consumers are actively moving away from conventional tobacco toward natural alternatives. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/1fbifKVRz4

[Cabbacis @cabbacis]

The global smoking cessation market is valued at ~$25B & growing at 12% CAGR — millions of adult smokers are actively seeking better options. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/FDinvuITSR

#HarmReduction

[Cabbacis @cabbacis]

The FDA proposed cutting nicotine in cigarettes to near-zero — a landmark shift that validates the case for lower-nicotine alternatives. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/jClxSJSJ5V

#HarmReduction

[Cabbacis @cabbacis]

FDA leadership signals a more innovation-friendly path for nicotine alternatives, accelerating harm reduction across the industry. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/nwq1dtI8z9

[Cabbacis @cabbacis]

Research continues to highlight how nicotine levels play a central role in addiction dynamics. Cabbacis supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

Article: https://t.co/nD4YJwWgl7

#HarmReduction #NicotineScience #PublicHealth $CABI

[Cabbacis @cabbacis]

U.S. regulators are advancing proposals to significantly reduce nicotine levels in cigarettes, reflecting growing policy focus on nicotine exposure. $CABI supports this shift with lower-nicotine, hemp-enhanced products developed for adult use.

https://t.co/i6eGrLamLQ

#Hemp